{"version":"1.0","type":"link","title":"Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer: A Randomized Clinical Trial.","author_name":"Wortelboer N 외","author_url":"https://prs-insight.online/author/Wortelboer%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/78565","thumbnail_width":1200,"thumbnail_height":630}